- Home
- EWTX vs TRMD Comparison
EWTX vs TRMD Comparison
Compare EWTX & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EWTX | TRMD |
|---|---|---|
| Founded | 2017 | 1889 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.5B |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | EWTX | TRMD |
|---|---|---|
| Price | $38.15 | $37.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 2 |
| Target Price | ★ $52.62 | $41.50 |
| AVG Volume (30 Days) | 1.4M | ★ 2.0M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 11.57% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.92 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.68 | $19.30 |
| 52 Week High | $48.51 | $41.86 |
Technical Indicators
Market Signals| Indicator | EWTX | TRMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.39 | 49.67 |
| Support Level | $37.75 | $28.19 |
| Resistance Level | $41.22 | $38.73 |
| Average True Range (ATR) | 1.68 | 1.26 |
| MACD | -0.17 | -0.35 |
| Stochastic Oscillator | 39.04 | 3.33 |
Price Performance
Historical ComparisonAbout EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.
About TRMD TORM plc
TORM PLC operates as a shipping company mainly owning and operating a fleet of product tankers. It is engaged in the transportation of refined oil products and clean petroleum products, including gasoline, jet fuel, naphtha, and diesel oil. The Company operates through two segments: the Tanker segment and the Marine Engineering segment, deriving the majority of its revenue from the Tanker segment.